FDA Approved: DEFERASIROX — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Deferasirox from Zydus Pharmaceuticals USA Inc. under an ANDA, indicating an update to labeling or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload Due to Blood Transfusions

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

SUPPL AP for DEFERASIROX (DEFERASIROX)